Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Waterboer

Showing results (401-410 of 431) with videos related to

Pageof 44
Sort By:
Vaccine|November 29, 2022
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccinationSmita Joshi, Devasena Anantharaman, Richard Muwonge, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2017
Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort studyJan N Bouwes Bavinck, Mariet C W Feltkamp, Adele C Green, et al.
International Journal of Cancer|September 11, 2023
Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sexJohannes M A Kusters, Brenda Diergaarde, Andrew Ness, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2022
Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort ConsortiumHilary A Robbins, Aida Ferreiro-Iglesias, Tim Waterboer, et al.
German Medical Science : GMS E-Journal|July 14, 2025
Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinomaAndreas Dietz, Kathy Taylor, Oliver Bayer, et al.
International Journal of Cancer|January 25, 2023
A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markersSanjeev Budhathoki, Brenda Diergaarde, Geoffrey Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2026
Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR studyDanni Cheng, Katrina Hueniken, Tianzhichao Hou, et al.
Papillomavirus Research (Amsterdam, Netherlands)|March 27, 2018
Are two doses of human papillomavirus vaccine sufficient for girls aged 15-18 years? Results from a cohort study in IndiaNeerja Bhatla, Bhagwan M Nene, Smita Joshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck CancersMichael E Bryan, Ling Aye, Dipon Das, et al.
International Journal of Cancer|January 30, 2018
Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancerJulia Butt, Mazda Jenab, Martina Willhauck-Fleckenstein, et al.
Pageof 44

Showing results (401-410 of 431) with videos related to

Sort By:
Pageof 44
Vaccine|November 29, 2022
Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccinationSmita Joshi, Devasena Anantharaman, Richard Muwonge, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2017
Human papillomavirus and posttransplantation cutaneous squamous cell carcinoma: A multicenter, prospective cohort studyJan N Bouwes Bavinck, Mariet C W Feltkamp, Adele C Green, et al.
International Journal of Cancer|September 11, 2023
Diagnostic accuracy of HPV16 early antigen serology for HPV-driven oropharyngeal cancer is independent of age and sexJohannes M A Kusters, Brenda Diergaarde, Andrew Ness, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 14, 2022
Absolute Risk of Oropharyngeal Cancer After an HPV16-E6 Serology Test and Potential Implications for Screening: Results From the Human Papillomavirus Cancer Cohort ConsortiumHilary A Robbins, Aida Ferreiro-Iglesias, Tim Waterboer, et al.
German Medical Science : GMS E-Journal|July 14, 2025
Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinomaAndreas Dietz, Kathy Taylor, Oliver Bayer, et al.
International Journal of Cancer|January 25, 2023
A risk prediction model for head and neck cancers incorporating lifestyle factors, HPV serology and genetic markersSanjeev Budhathoki, Brenda Diergaarde, Geoffrey Liu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 2, 2026
Genetically proxied inhibition of cholesterol-lowering drug targets and survival in HPV-positive and non-HPV driven head and neck cancer: a multicentre MR studyDanni Cheng, Katrina Hueniken, Tianzhichao Hou, et al.
Papillomavirus Research (Amsterdam, Netherlands)|March 27, 2018
Are two doses of human papillomavirus vaccine sufficient for girls aged 15-18 years? Results from a cohort study in IndiaNeerja Bhatla, Bhagwan M Nene, Smita Joshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 20, 2025
Direct Comparison of Alternative Blood-Based Approaches for Early Detection and Diagnosis of HPV-Associated Head and Neck CancersMichael E Bryan, Ling Aye, Dipon Das, et al.
International Journal of Cancer|January 30, 2018
Prospective evaluation of antibody response to Streptococcus gallolyticus and risk of colorectal cancerJulia Butt, Mazda Jenab, Martina Willhauck-Fleckenstein, et al.
Pageof 44